24 /100
LOW RISK
Score updated May 30, 2026

BBOT — BridgeBio Oncology Therapeutics, Inc. Dilution Risk Tracker

Track BBOT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BBOT — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
40
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for BBOT.
🔔 Track BBOT — Get forecast alerts →

💹 Market Data

Market Cap$718.56M
Shares Outstanding80.11M
Float35.75M
Cash$252.28M
Debt$2.64M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 5.6% shares (2025Q4 vs prior)
54 institutional holders · 60.00M shares
#1 Cormorant Asset Management, LP 17.88M shares
#2 DEERFIELD MANAGEMENT COMPANY, L.P. 4.89M shares
#3 Omega Fund Management, LLC 3.29M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest3.28M
Days to Cover10.1
% of Float9.2%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2025
3 FORM3 Apr 30, 2026
3 FORM3 Apr 30, 2026
424B3 ATM Apr 29, 2026
424B3 ATM Apr 23, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track BBOT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BBOT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for BBOT
📊 BBOT FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 BBOT Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.